Delcath Systems Inc (DCTH) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $9.00
• Market Cap: $360.55M
• P/E Ratio: 340.33
• EPS: $0.03
• 52-Week High: $18.23
• 52-Week Low: $8.12

Market Sentiment

Delcath Systems Inc currently has a Bullish sentiment score of 0.45.

About Delcath Systems Inc

Delcath Systems, Inc. is a pioneering interventional oncology company focused on transforming treatment paradigms for patients suffering from primary and metastatic liver cancers in the U.S. and Europe. Headquartered in New York, the firm utilizes its proprietary technologies to facilitate targeted delivery of cancer therapies directly to the liver, optimizing therapeutic efficacy while reducing systemic toxicity. With a robust pipeline of clinical programs and a commitment to expanding its m...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Delcath Systems Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does DCTH pay dividends?

Delcath Systems Inc (DCTH) does not currently pay a regular dividend.

What is DCTH's P/E ratio?

Delcath Systems Inc has a price-to-earnings (P/E) ratio of 340.33.

What is DCTH's market cap?

Delcath Systems Inc (DCTH) has a market capitalization of $360.55M with a current stock price of $9.00.